Stanford Institutes of Medicine Summer Research Program

Jasper Therapeutics to Host Key Opinion Leader Webinar on the Potential of Briquilimab for Chronic Urticaria on October 11, 2023

Retrieved on: 
Monday, October 9, 2023
CSU, Basophil, Antibody, Biology, Inflammation, Apoptosis, Risk, Rockefeller, KOL, Stanford University School of Medicine, Survival, FCR, Microbiology, B cell, Transplant, Patient, Stem cell factor, Infection, Therapy, Stanford Institutes of Medicine Summer Research Program, CD117, Fraunhofer Society, Berlin, Immunology, Immunity, S-1 Executive Committee, Hives, Syndrome, Pharmacology, SCF, Rockefeller University, FC, Executive Committee, Translational medicine, Vaccine, Pathology, Dermatology, Allergy, Jasper

Jasper’s leadership team will also provide an overview of upcoming clinical studies which will evaluate briquilimab’s potential as a therapeutic for both CSU patients and CIndU patients.

Key Points: 
  • Jasper’s leadership team will also provide an overview of upcoming clinical studies which will evaluate briquilimab’s potential as a therapeutic for both CSU patients and CIndU patients.
  • Briquilimab is an unconjugated aglycosylated anti-c-Kit antibody that blocks the interaction of the c-Kit receptor from its ligand, stem cell factor (SCF).
  • This mechanism of action disrupts the critical survival signal, leading to mast cell apoptosis thereby removing the underlying source of the inflammatory response in chronic urticaria.
  • He is also a member of the Executive Committee of the Stanford Institute for Immunity, Transplantation and Infection.

Lily Jan and Eve Marder to receive 2023 Pearl Meister Greengard Prize

Retrieved on: 
Friday, September 15, 2023
Nobel Prize, Neuron, National academy, Vincent Astor, Jack, Society, The arts, University, Partnership, BRAIN Initiative, Stanford Institutes of Medicine Summer Research Program, Rockefeller University, Academia Sinica, Howard Hughes Medical Institute, Woman, American Academy, Brandeis University, Brain, Metropolitan Museum of Art, Homeostasis, Potassium, Natural history, Museum, American Museum, Entomology, Neuroscience, Biophysics, Nobel Prize in Physiology or Medicine, Pearl Meister Greengard Prize, Metropolitan, Behavior, Peptide, Pharmaceutical industry, Medicine, Art, Science, Physiology

NEW YORK, Sept. 15, 2023 /PRNewswire/ -- Groundbreaking neuroscientists Lily Jan and Eve Marder will jointly receive the 2023 Pearl Meister Greengard Prize, an award which recognizes outstanding women scientists.

Key Points: 
  • NEW YORK, Sept. 15, 2023 /PRNewswire/ -- Groundbreaking neuroscientists Lily Jan and Eve Marder will jointly receive the 2023 Pearl Meister Greengard Prize, an award which recognizes outstanding women scientists.
  • "This year's awardees are two outstanding scientists who have made fundamental contributions to neurobiology," says Michael W. Young , Richard and Jeanne Fisher Professor, Nobel Laureate, and chair of the Pearl Meister Greengard Prize selection committee.
  • Marder, most recognized for her work understanding the modulation of neural networks, is the Victor and Gwendolyn Beinfield University Professor at Brandeis University.
  • To attend the Pearl Meister Greengard Prize ceremony and learn more about the award, register here .

Analysis Group and Stanford University Study Details Impact of California's "Balance Billing" Law on the Cost of Anesthesia Care

Retrieved on: 
Thursday, August 17, 2023
Insurance, Database, Research fellow, Health policy, Stanford School, Stanford University, Economic Policy (journal), Assistant, Analysis Group, Economics, Stanford University School of Medicine, Legislation, Patient, Fellow, Research, Stanford Institute for Economic Policy Research, Stanford Institutes of Medicine Summer Research Program, Biology, Health insurance, Anesthesiology, Anesthesia

The 2017 law's impact on the cost for anesthesiology services provided in network has been contentious, yet has not been fully studied until now.

Key Points: 
  • The 2017 law's impact on the cost for anesthesiology services provided in network has been contentious, yet has not been fully studied until now.
  • The results suggest that the California law's implementation was associated with a statistically significant decline in payments for out-of-network anesthesia care (by 13.6%, or $108 on average) and an increase in payments for in-network anesthesia care (by 3%, or $87 on average).
  • The analysis did not find a statistically significant change in the portion of claims occurring out of network.
  • The study, titled "Association Between 'Balance Billing' Legislation and Anesthesia Payments in California: A Retrospective Analysis," was published in the July issue of Anesthesiology .

PepsiCo collaborates with Stanford Institute for Human-Centered Artificial Intelligence to shape responsible AI standards

Retrieved on: 
Thursday, June 29, 2023
Faculty, Chain, Partnership, Transformation, Education, CPG, Policy, University, Intelligence, Research, Final good, Personalization, Sustainability, Forecasting, Organization, AI, Environment, Stanford Institutes of Medicine Summer Research Program, Medical device, Sales, Management, PepsiCo

PURCHASE, N.Y., June 29, 2023 /PRNewswire/ -- PepsiCo, Inc. (NASDAQ: PEP) today announced a collaboration with the Stanford Institute for Human-Centered Artificial Intelligence, an organization dedicated to guiding and building the future of artificial intelligence. As the first CPG company to join Stanford HAI's Corporate Affiliate Program, PepsiCo aims to be the global corporate leader in industrialized AI applications and responsible AI and gain insights that advance research, education, policy and practice throughout the industry.

Key Points: 
  • PURCHASE, N.Y., June 29, 2023 /PRNewswire/ -- PepsiCo, Inc. (NASDAQ: PEP) today announced a collaboration with the Stanford Institute for Human-Centered Artificial Intelligence, an organization dedicated to guiding and building the future of artificial intelligence.
  • As the first CPG company to join Stanford HAI's Corporate Affiliate Program, PepsiCo aims to be the global corporate leader in industrialized AI applications and responsible AI and gain insights that advance research, education, policy and practice throughout the industry.
  • "At PepsiCo, we firmly believe that AI should augment the human experience and will contribute to our digitalization efforts throughout the company," said Athina Kanioura, Chief Strategy and Transformation Officer at PepsiCo.
  • AI and Organizational Design – AI establishes a more agile decision-making process, allowing associates to focus on creative and strategic work.

Dr. Fei-Fei Li Earns WTF Innovators Award

Retrieved on: 
Wednesday, June 28, 2023
Database, Knowledge, ImageNet, Education, HAI, National Academy of Engineering, Deep learning, Policy, Stanford University, American Academy, CNN Millennium, CS, Human, Research, NAM, NAE, History, SALT, Radar, National academy, National Academy of Medicine, Stanford Institutes of Medicine Summer Research Program, Machine learning, AAAS, American Academy of Arts and Sciences, Medical device, AI

The WTF Innovators Award recognizes excellence at the precipice of societal change, with the inaugural class focusing on AI innovators.

Key Points: 
  • The WTF Innovators Award recognizes excellence at the precipice of societal change, with the inaugural class focusing on AI innovators.
  • As a memento, each of the 34 awardees are gifted a featured song by QuHarrison Terry and Genesis Renji.
  • We present "A.I.4.A", produced by Hatplane , to Dr. Fei-Fei Li.
  • Beyond her technical contributions, Dr. Li co-founded AI4ALL , a nonprofit dedicated to increasing diversity and inclusion in AI education, research, development, and policy.

Project Liberty Expands Global Alliance to Strengthen Democracy and Responsible Technology

Retrieved on: 
Wednesday, June 14, 2023
Networking hardware, Partnership, Social, Democracy, Stanford University School of Humanities and Sciences, Stanford University, Internet, Georgetown, Policy, Civic, Project Liberty, Research, Georgetown University, Silicon, Digital technology, Ethics, Humanities, Stanford Law School, McCourt, Algorithm, School, Conway Hall Ethical Society, Technology Hub, AI, Sciences Po, Project Liberty Ship, Health, Society, Stanford Institutes of Medicine Summer Research Program, Social media, Safety, Cryptocurrency, Renewable energy

NEW YORK, June 14, 2023 /PRNewswire/ -- Project Liberty today announced that Stanford University has joined Project Liberty's institute (formerly The McCourt Institute) as a founding partner, alongside Georgetown University and Sciences Po, to collaborate on advancing a more responsible approach to digital technology worldwide.

Key Points: 
  • Launched in 2021 by founder and civic entrepreneur Frank McCourt, Jr., Project Liberty is an independent, international nonprofit to advance responsible development of the internet of tomorrow, designed and governed for the common good.
  • "Project Liberty and its institute aim to foster a global network of the most innovative thinkers on technology for the common good.
  • "Tech companies have a disproportionate influence and power over our lives," said Martina Larkin, CEO of Project Liberty.
  • Working with Stanford and our other institute partners will accelerate research and the emergence of responsible technology."

Stanford Medicine and Stanford Institute for Human-Centered Artificial Intelligence announce RAISE-Health, a responsible AI initiative

Retrieved on: 
Wednesday, June 14, 2023
Online Privacy, Technology, Health Technology, Health Insurance, Artificial Intelligence, Healthcare Reform, Public Policy, Government, Hospitals, University, IOT (Internet of Things), Education, Biotechnology, Health, Security, Practice Management, Managed Care, General Health, Other Technology, Telemedicine, Virtual Medicine, Internet, White House, Federal Government, State, Local, Other Health, Pew, Stanford University, HAI, Intelligence, Multimedia, Research, Doctor of Philosophy, Stanford University School of Medicine, Silicon, Student, Hospital, MD, Patient, Faculty, Equitable, Responsibility, Stanford Institutes of Medicine Summer Research Program, Medical device, AI, Medicine

Responding to rapid advances in artificial intelligence and the urgent need to define its responsible use in health and medicine, Stanford Medicine and the Stanford Institute for Human-Centered Artificial Intelligence (HAI) today announced the launch of RAISE-Health (Responsible AI for Safe and Equitable Health).

Key Points: 
  • Responding to rapid advances in artificial intelligence and the urgent need to define its responsible use in health and medicine, Stanford Medicine and the Stanford Institute for Human-Centered Artificial Intelligence (HAI) today announced the launch of RAISE-Health (Responsible AI for Safe and Equitable Health).
  • This pioneering initiative seeks to address critical ethical and safety issues surrounding AI innovation and help others navigate this complex and evolving field.
  • View the full release here: https://www.businesswire.com/news/home/20230614192814/en/
    Stanford School of Medicine dean Lloyd Minor, MD, and Stanford HAI co-director and computer science professor Fei-Fei Li, PhD, will co-lead the RAISE-Health (Responsible AI for Safe and Equitable Health) initiative.
  • Both awareness of AI and skepticism about its use in health care have skyrocketed in the last 12 months.

Jasper Therapeutics Announces Appointment of Stephen J. Galli, M.D. to Scientific Advisory Board

Retrieved on: 
Wednesday, May 10, 2023
Asthma, MGH, Microbiology, Beth Israel Deaconess Medical Center, Basophil, Food allergy, Genomics, International Chinese Language Program, United States Air Force Scientific Advisory Board, Stanford University, Personalized medicine, Atopic dermatitis, Experimental pathology, Research, B cell, Harvard College, Cell, Assistant, Harvard Medical School, MDS, Galli, Immunity, Geisel School of Medicine, Division, Transplant, Executive Committee, Stanford University School of Medicine, Biology, Faculty, Knowledge, Immunology, BMS, S-1 Executive Committee, Hospital, Health, CD117, Massachusetts General Hospital, Therapy, Stanford Institutes of Medicine Summer Research Program, Anatomical pathology, Disease, Pathology

Professor at Stanford Medicine, to the company’s Scientific Advisory Board.

Key Points: 
  • Professor at Stanford Medicine, to the company’s Scientific Advisory Board.
  • “We are thrilled to welcome Dr. Galli to our Scientific Advisory Board,” said Ron Martell, CEO of Jasper Therapeutics.
  • “Dr.
  • Galli is an internationally recognized researcher who has made pioneering contributions to the field of immunology.

Accelerating Clinical Research: Challenges, Opportunities & Technologies for Real-Time Decision Making by CROs and FSPs, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, April 17, 2023
Lead, Stanford Institutes of Medicine Summer Research Program, Head, Clinical trial, Data collection, PMP, BSN, Aggregation, Assistant Secretary for Health, Master of Science, Associative entity, Growth, ChromeOS, Medical device, Fine chemical, Parexel

TORONTO, April 17, 2023 /PRNewswire-PRWeb/ -- Clinical research has been continually transforming through the adoption of new pathways, tools, technologies and techniques. A report by the Institute of Medicine (US) RoundTable on R&D found that an average clinical trial generates up to three million data points and counting. Such developments are increasing the complexity of data collection, cleanup, aggregation and analysis.

Key Points: 
  • Attendees will gain insights into the decision-making process in selecting the right platform for their clinical trial needs.
  • TORONTO, April 17, 2023 /PRNewswire-PRWeb/ -- Clinical research has been continually transforming through the adoption of new pathways, tools, technologies and techniques.
  • Clinical Research Organizations (CROs) and Functional Service Providers (FSPs) play substantial and unique roles in the conduct of clinical trials.
  • Many CROs and FSPs have successfully met these challenges, created opportunities for growth in the marketplace and are advancing clinical research.

‘Negative Evidence’ on COVID-19 Vaccines and Cancer Reviewed in the Journal of American Physicians and Surgeons (AAPS)

Retrieved on: 
Tuesday, March 21, 2023
Vaccine, DNA, Human, Stanford Institutes of Medicine Summer Research Program, Vaccination, Genetics, Pharmacovigilance, Physician, AAPS, Marie Cassidy, COVID-19, Cancer, Association of American Physicians and Surgeons, Gene expression, RNA, Messenger, Journal, Orthornavirae, Government agency, VAERS, Vaccine Adverse Event Reporting System, Social media, DSM-IV codes, Safety, Pharmaceutical industry, Surgeon

Government agencies have assiduously sought to detect even the slightest carcinogenic properties of any product to which humans are frequently exposed, states Dr. Orient.

Key Points: 
  • Government agencies have assiduously sought to detect even the slightest carcinogenic properties of any product to which humans are frequently exposed, states Dr. Orient.
  • A dedicated registry is essential, she explains, because conventional surveillance systems, like the Vaccine Adverse Event Reporting System (VAERS) are not designed to pick up delayed effects.
  • The article explores various theoretical mechanisms for inducing cancer.
  • The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS) , a national organization representing physicians in all specialties since 1943.